AtCor Medical is a leader in developing and marketing cardiovascular technologies for risk assessment and patient management.
AHA 2005

At the recent American Heart Association meeting in Dallas two major outcome studies were presented. The ASCOT-CAFE and STRONG Heart Studies both utilised the SphygmoCor Px System and clearly demonstrate the clinical importance of measuring central blood pressure.

Click here for more information.

VIEW PRODUCT DEMONSTRATION

The SphygmoCor system provides a quick and non-invasive method of obtaining key cardiovascular data thereby enhancing the treatment and management of patients.

Click below to view a brief demonstration of the steps involved in taking a SphygmoCor measurement. 

Click here for demonstration

NEWS

23 August 2007 : ASX Preliminary Year End Information 2007

26 July 2007 : AtCor Medical announces FY2007 contracted revenue increases 86% to $6.3 m

26 July 2007 : AtCor Medical announces fourth quarter report - Appendix 4C

18 July 2007 : AtCor Medical announces pharmaceutical trial contract with new US client